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Background: Megakaryopoiesis allows platelet formation, which is necessary for coagulation, also playing an
important role in different pathologies. However, this process remains to be fully characterized. C3G, an activator of
Rap1 GTPases, is involved in platelet activation and regulates several differentiation processes.
Methods: We evaluated C3G function in megakaryopoiesis using transgenic mouse models where C3G and C3GΔCat
(mutant lacking the GEF domain) transgenes are expressed exclusively in megakaryocytes and platelets. In addition, we
used different clones of K562, HEL and DAMI cell lines with overexpression or silencing of C3G or GATA-1.
Results: We found that C3G participates in the differentiation of immature hematopoietic cells to megakaryocytes.
Accordingly, bone marrow cells from transgenic C3G, but not those from transgenic C3GΔCat mice, showed increased
expression of the differentiation markers CD41 and CD61, upon thrombopoietin treatment. Furthermore, C3G
overexpression increased the number of CD41+ megakaryocytes with high DNA content. These results are supported
by data obtained in the different models of megakaryocytic cell lines. In addition, it was uncovered GATA-1 as a
positive regulator of C3G expression. Moreover, C3G transgenic megakaryocytes from fresh bone marrow explants
showed increased migration from the osteoblastic to the vascular niche and an enhanced ability to form proplatelets.
Although the transgenic expression of C3G in platelets did not alter basal platelet counts, it did increase slightly those
induced by TPO injection in vivo. Moreover, platelet C3G induced adipogenesis in the bone marrow under
pathological conditions.
Conclusions: All these data indicate that C3G plays a significant role in different steps of megakaryopoiesis, acting
through a mechanism dependent on its GEF activity.
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C3G, also known as RAPGEF1, is a guanine nucleotide ex-
change factor (GEF) for several members of the Ras super-
family of GTPases, mainly Rap1 and R-Ras [1, 2]. C3G is
essential for mouse embryonic development, since C3G
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These defects were rescued by the expression of active
Rap1 or R-Ras, suggesting the importance of the GEF func-
tion of C3G in cell adhesion, spreading and embryogenesis.
Several studies suggested a role for C3G in cell differen-
tiation. Overexpression of C3G induces neurite outgrowth
in rat pheochromocytoma (PC12) and human neuroblast-
oma (IMR-32) cells [4, 5], and is also required in later
stages of neuronal differentiation [6]. This effect of C3G,
which is dependent of its catalytic domain, is accompanied
by the repression of the cell cycle progression through thele is distributed under the terms of the Creative Commons Attribution 4.0
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tein levels increase during the differentiation of monocytes
to macrophages [7] and the interaction between Crk and
C3G is required for adipocyte differentiation [8]. In
addition, C3G overexpression induces myogenic differen-
tiation of mouse mesenchymal C2C12 cells and MEFs,
through Akt activation and cyclin D1 repression [9]. Fi-
nally, mice expressing a hypomorphic allele for C3G show
differentiation deficiencies in a variety of cell types [10].
Megakaryopoiesis is the process by which mature
megakaryocytes (MKs) develop from hematopoietic stem
cells (HSC). This is a complex process that involves the
commitment of HSC to the megakaryocyte lineage, pro-
liferation of progenitors, megakaryocyte (MK) matur-
ation and terminal differentiation to produce platelets
(thrombopoiesis) [11]. Immature MKs or megakaryo-
blasts, undergo changes in their cell surface markers,
followed by several cycles of endomitosis to increase
their size and DNA content. In addition, immature MKs
increase their reservoir of granules and cytoskeletal pro-
teins and form the Invaginated Membrane System
(IMS), also known as Demarcation Membrane System o
DMS [12]. Mature megakaryocytes then begin the
process of shedding their cytoplasm to produce platelets,
a complex process that requires the formation of elon-
gated structures called proplatelets.
The Rap1 isoform, Rap1b, is highly expressed in both
mature megakaryocytes and platelets, and it is expressed
at lower levels in immature megakaryocytes [13]. Rap1b
plays an essential role in most platelet functions, including
aggregation, coagulation, adhesion and spreading, through
activation of the platelet integrin αIIbβ3 [14, 15]. Throm-
bopoietin (TPO) induces the differentiation of megakaryo-
cytes through its receptor Mpl (myeloproliferative virus
ligand). This requires the sustained activation of the Rap1/
B-Raf/ERK1/2 pathway [13], the participation of Akt, Jak2
and JNK pathways and the production of ROS [16, 17].
Rap1-mediated activation of the ERK1/2 signaling path-
way has been shown to occur via C3G [18]. In fact, al-
though the specific Rap1-GEFs downstream of TPO have
not been identified, an association of a CrkL/C3G com-
plex with Mpl has been described [19, 20].
In this line, using transgenic mouse models, our group
has established a new role for C3G in platelet activation
and aggregation, both in vitro and in vivo [21]. C3G me-
diates platelet functions triggered by thrombin, ADP,
PMA and collagen through the activation of Rap1. In
particular, C3G is a mediator of Rap1 activation induced
by thrombin and PMA via PKC pathways [21]. The C3G
function in platelets is supported by other investigators,
who have proposed the formation of a ternary complex,
C3G/CrkL/VASP that regulates Rap1b [22]. In addition,
we have recently described a role of C3G in platelet se-
cretion, mainly through GEF-independent mechanisms.Thus, transgenic expression of C3G in platelets modu-
lates α-granule exocytosis through interaction with
VAMP-7, which results in an overall proangiogenic
secretome, facilitating inflammatory angiogenesis and
tumor metastasis [23].
Transcription factors of the GATA family play an im-
portant role in the regulation of genes involved in MK
differentiation. Particularly, GATA-1-binding motifs [(A/
T)GATA(A/G)] have been identified in the promoters
and/or enhancers of megakaryocyte-specific genes [24].
In this paper we have explored the putative role of C3G
in megakaryocyte differentiation, based on (i) its participa-
tion in the differentiation of several cell types and (ii) its
function in platelet physiology. Our findings indicate that
indeed, C3G, whose expression is regulated by GATA-1, is
involved in different stages of the megakaryocyte differen-
tiation, from the acquisition of surface markers and ploidy
features to the formation of proplatelets.
Methods
Transgenic mouse models
Transgenic mice used in this work have been previously
described [21]. C3G (full-length) and C3GΔCat (deleted
in the catalytic region) transgenes from human origin
are expressed under the control of the megakaryocyte
and platelet specific PF4 gene promoter. Transgenic
C3G (Tg-C3G) lines 2C1 and 6A6 were used. For trans-
genic C3GΔCat (Tg-C3GΔCat), line 8A3 was used. All
mice used in these studies were 8–12 week-old.
Cell lines and Bone Marrow cell cultures
K562 (ATCC, CCL243) and HEL (ATCC TIB-180)
leukemic cell lines were maintained in RPMI-1640
medium supplemented with 10% Fetal Bovine Serum
(FBS), 2 mM Glutamine, 100 U/ml Penicillin and 100 μg/
ml Streptomycin (Gibco). HEK-293 T (ATCC,
CRL-3216, human embryonic kidney) and B16-F10
(ATCC, CRL-6475, murine melanoma) cell lines were
grown in DMEM medium (Sigma) containing 10% FBS,
2 mM Glutamine, 100 U/ml Penicillin and 100 μg/ml
Streptomycin. The megakaryocytic cell line, Dami, was
grown in IMDM medium (Gibco) supplemented with
10% horse serum (HyClone), 20 mM Hepes, 100 U/ml
Penicillin and 100 μg/ml Streptomycin (Gibco). Dami
cells overexpressing GATA-1 fusioned to V5 and those
expressing the empty lentiviral vector pLenti6 V5/LacZ
(Gateway) were also grown in this medium but in the
presence of 2 μg/ml blasticidine.
Bone marrow cells (BMCs) were obtained from femora
and tibiae of transgenic mice by flushing with PBS. The
megakaryocytes were enriched by culturing BMCs in
IMDM with 10% FBS, streptomycin/penicillin and 50
ng/ml TPO for 5 days. For some experiments, the eryth-
rocytes were removed from the isolated BMCs by
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(RBC) lysis buffer (155 mM NH4Cl, 10 mM KHCO3, 0.1
mM EDTA pH 7.4).
Megakaryocytic differentiation and maturation in cell
lines and BMCs
For MKs differentiation and maturation, cell line cul-
tures were treated with 20 nM phorbol 12-myristate
13-acetate (PMA, Sigma) for 10 days. BMCs were incu-
bated with 50 ng/ml recombinant mouse thrombopoietin
(TPO, Miltenyi) in combination with 10 ng/ml Stem Cell
Factor (SCF, Miltenyi), 10 ng/ml Interleukin-3 (IL-3,
Invitrogen), 10 ng/ml IL-11 (Miltenyi) and 10 ng/ml IL-6
(Miltenyi) for 6 days.
Cell transfections
K562 cells were permanently transfected with pLTR2-
C3G [25], pSuper-C3Gi [26] and CRISPR-C3G (Santa
Cruz Biotechnology, Inc.) and the corresponding empty
vectors (pLTR2-CT, pSuper-CT and CRISPR-CT), for
up-regulation, down-regulation or abrogation of C3G
expression, respectively, using the Gene Pulser Electro-
poration System (Bio-Rad). Additionally, the pLTR2
clones were co-transfected with pSuper.gfp/neo vector
to express GFP fluorescence (pLTR2-CT/GFP and
pLTR2-C3G/GFP clones). These clones were maintained
with complete medium supplemented with 1:20 Killer
Hat solution [25], 250 μg/ml neomycin or 2 μg/ml puro-
mycin, as appropriate.
Lentiviral transduction
The expression of C3G in HEL cells was downregulated
by infection with second generation lentiviral particles,
which were generated by transient transfection of
HEK-293 T cells with psPAX2, pMD2.G and pLVTHM
(-CT or -C3Gi) vectors (Addgene), using PEI transfection
protocol. HEL cells were infected with the lentiviral parti-
cles containing the shRNA of C3G at a MOI of 25. Finally,
GFP+ cells were selected by single-cell isolation and clonal
expansion. The shRNA used to downregulate C3G expres-
sion was: 5′- CCACTATGATCCCGACTAT-3′.
Permanent GATA-1 silencing in Dami cells was per-
formed by infection with human GATA-1 shRNA lentiviral
particles (75,000 infectious units) containing a mixture of
different shRNAs (Santa Cruz Biotechnology sc-35,452-V)
in the presence of 10 μg/ml Polybrene (Santa Cruz Biotech-
nology sc-134,220). Cells were selected with puromycin
(1 μg/ml).
Cell lysis and Western blot
Cell line cultures were lysed using Cell Lysis buffer (Cell
Signaling Technology) supplemented with 25 μM NaF and
1mM PMSF. Total protein lysates were boiled with 2x
Laemmli buffer before being resolved on SDS-PAGE. PVDFmembranes were blotted using the following antibodies:
C3G H-300 (sc-15,359), p-C3G Tyr504 (sc-12,926),
α-globin H-80 (sc-21,005), ERK K-23 (sc-94) and GATA-1
N6 (sc-265) from Santa Cruz Biotechnologies, β-tubulin
(T5293) and β-actin (A5441) from Sigma and p21 Waf1/
Cip1 (2947) from Cell Signaling Technology.
Semi-quantitative PCR
RNA was reverse transcribed using SuperScript™ III
First-Strand Synthesis System (Thermofisher) to generate
DNA. Semi-quantitative PCR was performed using Bio-
Taq™ polymerase (Bioline) using the following primers: for
GPA: forward 5´-GGAATTCCAGCTCATGATCTCAGG
ATG-3′ and reverse 5´-TCCACATTTGGTTTGGTGAA
CAGATTC-3′; for CD61: forward 5´-TATAGCATT
GGACGGAAGGC-3′ and reverse 5´-GACCTCATTGT
TGAGGCAGG-3′; for GAPDH: forward 5´-TGCACCA
CCAACTGCTTAGC-3′ and reverse 5′- TCTTCTGGG
TGGCAGTGATG-3′.
Analysis of cell surface markers and DNA content by flow
cytometry
Megakaryocytic markers, CD41 and CD61, and erythroid
marker (GPA) were analyzed by flow cytometry using spe-
cific fluorochrome-conjugated antibodies: anti-human anti-
bodies for human cell lines from Immunostep (CD41-PE,
CD61-APC and GPA-FITC or GPA-PE) and anti-mouse
antibodies for mouse BMCs from eBiosciences (CD41-APC
and CD61-PE). After differentiation treatment, washed cells
were incubated in 100 μl of PBS with 0.5–1 μg of indicated
antibodies for 20min on ice. Then, cells were washed once
and the fluorescence was measured using FACSCalibur™
and BD Accuri™ cytometers and analyzed using FlowJo and
Accuri software, respectively.
To determine the ploidy status, after 6–10 days of dif-
ferentiation, cultures of cell lines and BMCs were har-
vested, washed with PBS and fixed with ethanol by the
addition of 0.5 ml of 70% ethanol dropwise. After incu-
bation for at least 1 h, cells were washed twice with PBS
and stained with anti-CD41-FITC antibody from BD
Pharmigen (BMCs only), as described before, and subse-
quently incubated with a mixture of 100 μg/ml RNase
(Promega) and 50 μg/ml Propidium Iodide (PI, Sigma) in
PBS for at least 40 min at RT in the dark. For the ana-
lysis, CD41+ cells were gated and cell doublets were ex-
cluded from the analysis. The ploidy distribution of the
CD41+ populations was determined using a BD Accuri™
cytometer.
Confocal immunofluorescence microscopy and may-
Grunwald-Giemsa staining
3 × 106 cells were seeded onto 6 cm plates containing
glass coverslips pre-coated with 5 μg/ml of fibronectin
(Sigma). Cells were incubated with serum-free media for
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then fixed with 3.7% paraformaldehyde (PFA, Sigma) for
15 min. Fixed cells were washed twice with PBS, perme-
abilized with 0.1% Triton X-100 (Sigma), and washed
again with PBS. Coverslips were blocked with 2% BSA
for 1 h, and then incubated for 1 h at RT with primary
antibody C3G #1008 [25], followed by incubation with
Cy5-anti-rabbit antibody. Nuclei were stained with DAPI
for 10 min. Coverslips were mounted with Mowiol® (Cal-
biochem). Images were obtained at the same exposure
time with a Leica TCS SP5 confocal microscope and pic-
tures were processed using LSM Image Browser, ImageJ
Software and ZEN lite Imaging Software.
For Giemsa staining, after 48 h of PMA treatment, cells
were centrifuged onto glass coverslips for 3min at 500 g
to allow cell attachment. Then, cells were fixed with 100%
ethanol and the slides were stained with May-
Grunwald-Giemsa.
Rap1 activity assay by immunofluorescence
Preparation of samples for detection of active Rap1 by
confocal microscopy was performed essentially as de-
scribed above, with some modifications [27, 28]. Ali-
quots of 1.5 × 106 cells in PBS were treated with 20 nM
PMA at indicated times and then immediately fixed by
adding 4% PFA for 20min at RT. Cells were washed with
PBS by centrifugation and permeabilized with 0.2% Tri-
ton + 1% BSA for 5 min at RT. Cells were then incubated
with 0.3 mg/ml GST-RalGDS-RBD purified protein for
45 min at RT, washed three times with PBS and incu-
bated with anti-GST for 1 h at RT. Cells were washed
three times with PBS, and incubated with Cy3 or
Cy5-conjugated anti-mouse antibodies for 1 h at RT.
Nuclei were stained with DAPI for 10 min. After wash-
ing, cells were centrifuged onto glass coverslips for 3
min at 500 g and mounted with Mowiol. Negative con-
trols were performed as follows: (1) without the
GST-RalGDS-RBD protein, as control of the specificity
of the anti-GST primary antibody; (2) by replacing
GST-RalGDS-RBD with GST alone at the same molarity;
(3) without anti-GST primary antibody, to detect any
non-specific staining by the secondary antibody. For ac-
tive Rap1, z-sections of 0.25 μm were acquired using
Leica TCS SP5 confocal microscope. All images were ob-
tained at the same exposure time and processed using
LSM Image Browser and ImageJ software.
CFU-MKs assay
A commercial collagen-based system (MegaCult-C, Stem-
Cell Technologies Inc.) was used to assay colony-forming
units (CFUs) of mouse megakaryocyte progenitors. Briefly,
2.2 × 106 freshly isolated BM cells were resuspended into
1ml IMDM medium (33x of the final cell concentration).
Then, 50 μl of this cell suspension was mixed with 150 μlof IMDM, containing cytokines at 11x of the final concen-
tration (1x: 50 ng/ml TPO, 20 ng/ml IL-6, 50 ng/ml IL-11
and 10 ng/ml IL-3) and 850 μl of MegaCult™ medium. Fi-
nally, 600 μl of cold collagen was added (≈1600 μl) and
750 μl of this final cell suspension was cultured into the
two wells of a double chamber slide (μ-Slide 2 well, Ibidi),
each containing ≈50,000 cells. Cultures were maintained
at 37 °C and 5% CO2 for 8 days. Collagen gels were dehy-
drated, fixed and stained according to the manufacturer’s
specifications. Acetylchorinesterase-positive colonies with
3 or more MKs were scored as CFU-MKs.
Time lapse analysis of bone marrow explants
Intact marrow was obtained by flushing mouse femora
with Tyrode’s-HEPES buffer (134mM NaCl, 0.34mM
NaHPO4, 2.9 mM KCl, 12mM NaHCO3, 20mM HEPES),
5 mM Glucose, 0.35% Albumin, 1mM MgCl2, 2 mM
CaCl2 and 10 U/ml Penicillin/Streptomycin) using a
21-gauge needle. The marrows were cut into 0.5–1mm
thick transverse sections with a surgical blade, under a
binocular microscope. The explants were placed in an in-
cubation chamber (μ-Slide 8 well IbiTreat, Ibidi) with Tyr-
ode’s-HEPES buffer containing 5% mouse serum and were
maintained at 37 °C for 6 h. MKs at the periphery of the
explant were monitored under an inverted microscope
(Nikon Eclipse TE2000-E), coupled to a video camera (Ha-
mamatsu Orca-er). The images were sequentially acquired
at 10min intervals for 6 h and then mounted and proc-
essed using ImageJ and Metamorph software.
To identify the MKs in the periphery of the explant,
anti-mouse CD41-APC antibody (eBiosciences) was
added to the Tyrode’s-HEPES buffer prior to placing the
explants in the incubation chamber. MKs were classified
according to the morphology: i) spherical megakaryo-
cytes, ii) megakaryocytes with protrusion and iii) mega-
karyocytes with proplatelets [29].
Isolation of cells from the bone matrix
To analyze the MKs associated to the osteoblastic
niche, after isolation of BMCs from the femur, the
remaining bones were cut into 1 mm pieces and incu-
bated with 1 mg/ml collagenase Type I (Sigma) and 1
mg/ml dispase Type II (Sigma) at 37 °C for 2 h under
vigorous stirring to detach the cells most tightly ad-
hered to the bone matrix.
Analysis of the number of platelets by flow cytometry
Blood (100–200 μl) was collected by submandibular
puncture from anesthetized mice (isoflurane), and antic-
oagulated with EDTA. Blood was washed with same vol-
ume of Tyrode’s-HEPES buffer plus 5 mM glucose, and
stained with anti-CD41-APC antibody for 15 min at RT.
The number of platelets was determined by measuring
50 μl of blood using a BD Accuri ™ cytometer.
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Mouse TPO (Molecular Innovations®) was administered
by intraperitoneal injection (5 μg per mouse). Platelet
number was determined, at the indicated time points, as
described above. Bone marrow cells were harvested 11
days after injection and the percentage of megakaryo-
cytes was analyzed by flow cytometry.
Platelet clearance analysis
Mice were injected, through the lateral tail vein, with
600 μg of hydroxysuccinimido-biotin (NHS-biotin, Sigma)
in 200 μl of buffer containing 140mM NaCl and 10%
DMSO. At the indicated time points, 20 μl of whole blood,
from submandibular puncture, was mixed with 200 μl ml
BSGC buffer (116mM NaCl, 13.6mM tri-sodium citrate,
8.6 mM Na2HPO4, 1.6 mM KH2PO4, 0.9 mM EDTA, 11,1
mM glucose) and 1ml of balanced salt solution (BSS; 149
mM NaCl, 3.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4,
7.4 mM HEPES, 1.2 mM KH2PO4, 0.8 mM K2HPO4, 3%
FBS). Cells were pelleted at 1400 g for 5 min and resus-
pended in PBS. Platelets were stained with CD41-APC for
15min, followed by PE-Streptavidin for 1 h on ice. Bio-
tinylated platelets were washed in BSS buffer and analyzed
by flow cytometry.
Tumor implantation and analysis of platelets, MKs and
adipocytes
1 × 106 B16-F10 melanoma cells in PBS were subcutaneously
injected into Tg-C3G and WT-C3G mice. After 15 days of
tumor growth, the BM was extracted, fixed in 4% formalde-
hyde, embedded in paraffin and stained with H&E. The num-
ber of MKs was quantified using an Ariol IHC Scanner,
based on the Area_score and the Intensity_score parameters
(Leyca Biosystems). The number of adipocytes was deter-
mined using the Adiposoft software (ImageJ), which discrimi-
nates particles between 4 and 30 μm. A visual double-check
was done to eliminate the false-positive results.
Statistical analysis
Data have been represented as the mean ± SEM (Standard
Error of the Mean) or the median ± SEM values of at least
3 independent experiments from each genotype. The
Kolmogorov-Smirnov test was performed to determine if
data fit into a normal distribution. To compare between
two experimental groups, unpaired Student’s t-test was
computed, when the data were normally distributed. The
Mann Whitney’s U-test was computed as a non-parametric
procedure when our data were not normally distributed.
In fluorescence measurements in cell lines cultures, due
to high variability in fluorescence intensities between inde-
pendent experiments, the data were normalized against
the control values. To calculate the significance between
the different experimental conditions, a two-way ANOVA
test was performed. Then, Holm-Sidak post-hoc pairwiseanalysis was calculated to determine the significant differ-
ences in groups two to two.
Results
C3G induces the acquisition of MK features, such as MK-
like morphology and expression of MK surface markers in
K562 and HEL cell lines
K562 and HEL are two cell lines with erythroid charac-
teristics widely used to study megakaryocytic differenti-
ation, since they can acquire megakaryocytic features
upon stimulation with TPO or phorbol esters. The first
evidence of the implication of C3G in MK differentiation
was the observation of a high proportion of K562 cells,
stably transfected with hC3G, with a megakaryocytic-like
morphology, i.e. large vacuolated cells with several mem-
brane extensions (Fig. 1a and Additional file 1: Figure
S1a). This morphology was similar to the acquired by
non-transfected K562 and HEL cells, upon PMA stimu-
lation (Fig. 1a & b). Moreover, the expression of C3G in-
creased during PMA-induced MK differentiation, mainly
in HEL cells, which suggests an implication of C3G in
this process (Fig. 1c). However, silencing of C3G expres-
sion did not modify the morphology of PMA-treated
K562 cells (Additional file 1: Figure S1a & 1b).
Based on the above results, we analyzed the expression
on the surface of the megakaryocyte markers CD41 and
CD61 in K562 clones with overexpression or silenced ex-
pression of C3G. C3G overexpression per se induced a sig-
nificant increase in CD41 and CD61 levels in two different
clones, pLTR2-C3G (Fig. 1d & e) and pLTR2-C3G/GFP
(Additional file 1: Figure S1c). Increased expression of
CD41 and CD61 in the pLTR2-C3G clone was coupled to a
slight decrease in the expression of the erythroid marker
GPA (Fig. 1d), which was confirmed by RT-PCR (Fig. 1f).
Accordingly, the expression of the erythroid marker
α-globin was highly decreased upon C3G overexpression
(Fig. 1g). Remarkably, the levels of CD41 and CD61 in-
duced by C3G overexpression were similar to those in-
duced by PMA treatment in control cells. PMA did not
further increase the levels of these MK markers induced by
C3G overexpression (Fig. 1d), indicating that C3G would
participate in the PMA-induced differentiation pathway.
On the other hand, C3G silencing or ablation did
not change the expression of these surface markers
(Additional file 2: Figure S2a & 2b), although an in-
crease in GPA expression, coupled to a slight decrease in
CD61 expression was observed by RT-PCR (Additional
file 2: Figure S2c). The increase in GPA expression was
also detected by flow cytometry (Additional file 2: Figure
S2a). Altogether, these results suggest that C3G is involved
in the induction of the expression of megakaryocytic
differentiation markers in K562 and HEL cells, thus con-
tributing to the commitment of these cells to the mega-
karyocytic lineage.
Fig. 1 Overexpression of C3G in K562 cells increases megakaryocytic markers. a May-Grünwald-Giemsa staining of the indicated K562 clones
untreated or treated with 20 nM PMA for 72 h. Scale bars: 20 μm. b Representative images showing the morphology of HEL cells after 24, 48 and
72 h of PMA treatment. Images were obtained using a Zeiss Axiovert 135 inverted microscope. Scale bars: 50 μm, c Analysis of C3G expression in
K562 and HEL cells stimulated with 20 nM PMA at the indicated times. Tubulin was used as loading control. C3G expression values are relative to
non-treated cells and normalized against tubulin (C3G/Tub). d Expression of CD41, CD61 and GPA markers was analyzed by flow cytometry using
specific fluorochrome-conjugated antibodies (CD41-APC, CD61-PE and GPA-FITC). Representative flow cytometry plots of untreated cells are
shown. Histograms represent the mean ± SEM of the fluorescence intensity (relative units) of CD41, CD61 and GPA from at least 4 independent
experiments of each clone, treated as indicated. 2-way ANOVA and Holm-Sidak analysis were done. **p < 0.01, ***p < 0.001. e Representative
Western blots showing C3G expression in the pLTR2 and pLTR2/GFP clones. The numbers represent C3G expression values relative to empty
vectors and normalized against tubulin (C3G/Tub), which was used as loading control. f Analysis of CD61 and GPA expression in untreated K562
clones, pLTR2-CT and pLTR2-C3G, by RT-PCR. The numbers represent expression values relative to pLTR2-CT expressing cells and normalized
against GAPDH, which was used as housekeeping gene. g Western blot analysis of α-globin and C3G in the indicated clones of K562, treated or
not with 2 μM STI-571, an inducer of erythroid differentiation in these cells, [46]. The expression of total ERK was used as loading control. α-
globin/ERK ratios are shown. All values are relative to control, non-treated cells. STI: STI-571 (Imatinib mesylate); CT: control
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during MK differentiation
At the end of the proliferation phase, megakaryocyte
precursors exit the normal cell cycle and undergo endo-
mitosis. In order to establish the role of C3G in thisphase of the MK differentiation we determined the
ploidy status induced by PMA in our K562 and HEL
clones. As shown in Fig. 2a, the percentage of polyploid
cells decreased in C3G-KO K562 cells, as compared to
control cells. This was accompanied by an increase in
Fig. 2 Overexpression of C3G in K562 increases polyploidization and p21 expression. The polyploidization state of K562-pLTR2/GFP and -CRISPR clones
was identified by propidium iodide staining after 10 days of differentiation with 20 nM PMA. Representative flow cytometry plots of ploidy distribution,
stacked bars and histograms corresponding to CRISPR clones (a) and pLTR2/GFP clones (b). We identified up to 4 different populations: diploid (2n),
tetraploid (4n) and polyploidy cells (8n and≥ 16n), indicating the percentage of cells corresponding to each population. Stacked bar histograms represent
the mean of the percentage of cells of each genotype belonging to the different ploidy populations. Histograms represent the mean ± SEM of the
quantification of the percentage of individual ploidy population. c Time course Western blot analysis of the expression of C3G (indicated by an arrow) and
p21 in K562 cells transfected with pLTR2/GFP plasmids (upper panels) or CRISPR plasmids (lower panels) treated with PMA (20 nM) for the indicated times.
Left panel: representative images of Western blot. Tubulin was used as loading control. The asterisk indicates a non-specific band. Right panel: Line/scatter
plots of p21 expression. Values are normalized with tubulin and relativized to control, non-treated cells (n= 2). The ANOVA analysis indicates that there are
statistically significant differences in p21 expression between pLTR2-CT and pLTR2-C3G at the different time points (p= 0.019)
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of polyploid cells was higher in the C3G-overexpressing
K562 cells, as compared to their controls (Fig. 2b).
The polyploidization of early MK progenitors re-
quires cell cycle arrest and entry into the endomitosis
cycle [30, 31]. p21Waf-1/Cip-1 (p21) is a potent inhibitor
of cyclin-dependent kinases (CDKs) involved in cell cycle
arrest of various cell types. p21 has been shown to be
highly expressed in mature megakaryocytes, suggesting animportant role of this protein in the proliferative arrest of
cells during MK differentiation [32].
With all these considerations, we analyzed the expres-
sion of p21 in our K562 clones with C3G overexpression
(pLTR2-C3G/GFP) or ablation (CRISPR-C3G). Figure 2c
shows a clear increase in p21 expression throughout the
treatment with PMA, which was maximum between 4
and 24 h of stimulation. Interestingly, C3G-overexpressing
K562 cells showed a ten-fold increase in p21 expression
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cells. In addition, these pLTR2-C3G/GFP cells maintained
higher sustained levels of p21 throughout the time course.
Moreover, decreased levels of p21 were observed in
CRISPR-C3G cells after 24 h of PMA treatment, although
in this case the data were not significant. This result indi-
cates that C3G would modulate the expression of p21,
thus contributing to cell cycle arrest.
PMA-induced C3G phosphorylation promotes a sustained
activation of Rap1
Since activation of C3G by phosphorylation on tyrosine 504
is required to carry out some of its functions [33], we ana-
lyzed the phosphorylation status of C3G in K562 cells treated
with 20 nM PMA at several time points (2, 5, 10, 30 and 60
min), using a specific anti-phospho-Tyr 504 antibody. Indeed,
PMA induced a transient increase in C3G phosphorylation
in K562 cells (Fig. 3a). Whereas in control, pLTR2-CT/
GFP-expressing, cells phospho-C3G levels peaked at 2min of
treatment with PMA, C3G-overexpressing cells showed in-
creased basal levels that were maintained throughout the
time course (Fig. 3b). Moreover, treatment with PMA in-
duced an increase in Rap1-GTP levels in cells with endogen-
ous C3G expression that were maximal between 2 and 5min
of stimulation and decreased after 10min. This indicates that
PMA promotes a transient activation of Rap1, as described
by other authors [15]. However, overexpression of C3G in-
duced a more sustained activation of Rap1, in correlation
with the sustained phosphorylation of C3G. Negative con-
trols of the immunofluorescence Rap1 activation assay are
shown in Additional file 3: S3. Overall, these results indicate
that C3G overexpression increases PMA-induced Rap1 acti-
vation and that phosphorylation of C3G in Y504 is important
for this effect.
GATA-1 regulates C3G expression during MK
differentiation
The hematopoietic transcription factor GATA-1 induces
the expression of genes involved in MK differentiation.
Accordingly, the silencing of GATA-1 in Dami cells pre-
vented, both the expression of CD41 and the polyploidi-
zation induced by PMA (Fig. 4a & b). A ChIP analysis
suggested the existence of binding sequences for
GATA-1 at evolutionary conserved sites corresponding
to C3G gene regulatory regions (Additional file 4: Figure
S4a-c). Therefore, GATA-1 could be a potential regula-
tor of C3G during megakaryocytic/platelet differenti-
ation. Indeed, overexpression of GATA-1 in Dami cells
increased C3G expression during PMA-induced MKs
maturation (Fig. 4c). Consequently, GATA-1 silencing
prevented the increase in C3G expression under PMA
treatment (Fig. 4d). Therefore, C3G would be a newly
identified mediator of GATA-1 involved in MK
differentiation.Transgenic C3G expression increases the proportion of
poliploid/mature megakaryocytes in primary bone
marrow cultures
The production of megakaryocytes from adult HSC of
bone marrow (BM), cultured in the presence of TPO
and a cocktail of cytokines, is an ex vivo model com-
monly used to study the mechanisms involved in the
expansion and differentiation of megakaryocytic pro-
genitors. To study, in this ex vivo model, the partici-
pation of C3G in megakaryopoiesis, we have used two
lineages of transgenic mice for C3G (2C1 and 6A6)
and one for C3GΔCat (8A3 lineage), where the trans-
genes are expressed under the PF4 gene promoter
[21, 23].
BM cultures from Tg-C3G mice harbored a higher
percentage of megakaryocytes than WT or Tg-C3GΔCat
mice, according to the statistically significant increase in
the CD41+ and double CD41+/CD61+ populations.
Moreover, there was a significant decrease in the per-
centage of CD41+/CD61+ megakaryocytes in bone mar-
row cultures derived from Tg-C3GΔCat mice, as
compared to WT and Tg-C3G cells (Fig. 5a & b). In
agreement with these results, although data did not
reach significance, we found a greater number of
acetylcholine-positive megakaryocyte colonies in BM
cultures from Tg-C3G mice, in comparison with their
WT controls (Fig. 5c).
Overall, these results indicate that C3G plays a posi-
tive role in the acquisition of megakaryocytic markers
upon TPO stimulation and increases the ability of MK
progenitors to proliferate and generate MK colonies.
This function of C3G is dependent on its catalytic, GEF
activity, in agreement with the results found in human
cell lines.
Next, we evaluated the ploidy status of CD41+ BM
cell population, obtained after 6 days of culture (Fig.
5d-f ). A significant increase in CD41+ cells with a
DNA content ≥8n was observed in the Tg-C3G 2C1
lineage (14% in Tg-C3G vs 9% in WT), which was
coupled to a significant decrease in 2n CD41+ cells
(64% in Tg-C3G vs 71% in WT). A similar tendency
was observed in the 6A6 lineage (≥8n population: 12%
in Tg-C3G vs 8% in WT). These results indicate that
overexpression of C3G in megakaryocytes induces a
higher rate of DNA replication. To verify these results,
polyploidization was analyzed in mature CD41+ mega-
karyocytes of the Tg-C3GΔCat mice. The results indi-
cate a DNA distribution in mature Tg-C3GΔCat
megakaryocytes similar to that of the WT (12% in
Tg-C3GΔCat vs 13% in WT), indicating that overex-
pression of this mutant did not affect endomitosis.
Altogether, these results support a role for C3G in the
acquisition of polyploid features, which seems to be
dependent on its GEF activity.
Fig. 3 PMA induces C3G phosphorylation in K562 cells, which correlates with a sustained Rap1 activation. a Left panel: time course Western blot
analysis of phospho-Y504-C3G (p-C3G) expression in non-transfected K562 cells treated with 20 nM PMA for 2, 5, 10, 30 and 60min. The expression of
total C3G and tubulin were used as loading controls. The asterisk indicates a non-specific band. Right panel: Histogram showing pY504-C3G/C3G
ratios, relativized to control, non-treated cells. b Representative immunofluorescence confocal microscopy images of the indicated K562 clones treated
with 20 nM PMA for 2, 5 and 10min, fixed, permeabilized and incubated with: anti-phospho-C3G/anti-rabbit Cy3 antibodies (green), purified GST-
RalGDS-RBD and anti-GST/anti-mouse Cy5 antibodies (red) to detect active Rap1-GTP, and DAPI (blue). The overlay images are made without DAPI
channel. Images of GFP expression are shown. Histograms represent the mean ± SEM of the integrated density (I.D.) of p-C3G (left panel) and Rap1-
GTP staining (right panel). The ANOVA analysis indicates that there is a significant variability between pLTR2-C3G and pLTR2-CT in the fluorescence
intensities of p-C3G and Rap1-GTP, independently of the treatment used (p < 0.05). In addition, Holm-Sidak method was done. *p < 0.05
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formation
Interaction of megakaryocytic progenitors with the BM
microenvironment is essential for proper megakaryopoi-
esis and subsequent development of megakaryocytes into
platelets. Upon physiological platelet demand, megakar-
yocyte progenitors migrate from the osteoblastic nichetoward the vascular niche in a process mediated by the
integrin αIIbβ3 [34]. To determine whether C3G regu-
lates megakaryocyte motility, we analyzed the migration
capacity of mature MKs in bone marrow explants of the
different genotypes in terms of migration velocity and
distance covered. As shown in Fig. 6a (upper box plots),
the migration velocity of MKs released from the bone
Fig. 4 GATA-1 regulates C3G expression in Dami cells. a Dami cells with a permanent GATA-1 knockdown (shGATA-1) or overexpression of the
fused protein V5-GATA-1 (a gift from Dr. Laura Gutiérrez, University of Oviedo), as well as their control cells (expressing empty vectors) were used.
Representative flow cytometry plots of the expression of CD41 marker in Dami cells treated with 100 ng/ml PMA for 96 h. Histograms represent
the mean ± SEM of the fluorescence intensity (relative units) of CD41 from 3 to 5 independent experiments of each clone. b Histograms
represent the mean ± SEM of the percentage of polyploidy (>4n) Dami cells stimulated with PMA for 96 h (n = 5). c Ectopic expression of GATA-1
in Dami cells induces C3G expression. Left panel: Western blot showing the expression of V5-GATA-1 protein or endogenous GATA-1 in Dami
cells. V5-GATA-1/β-actin or endogenous (End.) GATA-1/β-actin ratios are shown. Values were normalized against endogenous GATA-1 levels in
cells transfected with the empty vector. Right panel: C3G expression in Dami cells transfected with V5-GATA-1 or its control, stimulated with 100
ng/ml PMA for 96 h. Normalized C3G/β-actin ratios are shown. d Silencing of GATA-1 abolished PMA-induced C3G expression in Dami cells. Left
panel: Western blot showing GATA-1 levels in Dami cells. Values were normalized using β-actin. Righ panel: C3G expression in Dami cells with
silenced GATA-1 expression and treated with 100 ng/ml PMA for 96 h. Normalized C3G/β-actin ratios are shown
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higher in the Tg-C3G than in the WT explants. Similar
results were obtained with the 2C1 lineage, although in
this case differences were not statistically significant.
On the other hand, Tg-C3GΔCat MKs showed a signifi-
cant decrease in motility, compared to their WT MKs
(8A3 lineage). These data correlate with the results de-
rived from the analysis of the distance covered (Fig. 6a,
lower box plots).
In vivo proplatelet formation by megakaryocytes is
temporarily regulated by interactions with the extracellu-
lar matrix. In particular, interaction with type I collagen,
which is particularly abundant in the osteoblastic niche,
strongly inhibits proplatelet formation. To analyze the
interaction of our transgenic megakaryocytes with the
extracellular matrix of the bone marrow, we studied the
megakaryocyte progenitors most strongly associated
with the bone matrix, i.e. those that are only release
from the bone after treatment with collagenase and dis-
pase. Figure 6b shows that C3G overexpression (Tg-C3G
6A6 lineage) modestly decreases the percentage of MKprogenitors that are bound to the bone matrix, whereas
overexpression of the C3GΔCat mutant showed no ef-
fect. These data suggest that C3G could play a role in
the mobilization of mature megakaryocytes from the
osteoblastic niche to the vascular niche.
Next, we studied whether the increased production
and mobilization of MK, induced by C3G, was reflected
in a greater formation of proplatelets. BM explants were
maintained in a physiological buffer in the presence of
anti-CD41-APC antibody, and MK morphology was
monitored for 6 h by time-lapse microscopy. Results in
Fig. 6c showed a 10 and 20% increased proportion of
megakaryocytes extending proplatelets in explants from
Tg-C3G mice of the 2C1 and 6A6 lineages respectively,
compared to their WT. The implication of the catalytic
domain of C3G in this effect was verified by the decrease
of about 20% in the ability of the Tg-C3GΔCat MKs to
form proplatelets, as compared to its control (8A3
lineage). These results indicate that the overexpressed
C3G, through its catalytic domain, promotes the forma-
tion of proplatelets in mature megakaryocytes. The
Fig. 5 Tg-C3G expression promotes CFU-MKs and increases the percentage of mature megakaryocytes in BM in vitro. a Freshly isolated BM cells were
cultured with TPO for 6 days. The percentage of CD41+, CD61+ and double CD41+/CD61+ cells was analyzed by flow cytometry. Box plots represent the
median ± SEM of the percentage of positive cells of 6 different measures from three independent cultures of each genotype. Mann-Whitney U test was
done. *p< 0.05, **p< 0.01 and ***p< 0.001. b Table indicating the mean ± SEM of the percentage of positive cells of each genotype. c Representative
images of a CFU-MK from WT-C3G and Tg-C3G (2C1 lineage) BMs. Histograms represent the mean ± SEM of the total number of CFU-MKs in BM cultures
from 3 mouse of each genotype and 2 cultures per mouse. d Representative flow cytometry plots of ploidy distribution of FSChigh/CD41+ MKs (WT and
Tg). We identified up to 5 different populations; 2n, 4n, 8n, 16n and≥ 32n. The percentage of FSChigh/CD41+ MKs corresponding to each population is
indicated. e Stacked bar histograms of the percentage of MKs of each genotype belonging to the different ploidy populations (2n, 4n, 8n, 16n and≥ 32n)
of BM cells. Vertical bars indicate the percentage of cells with a DNA content ≥8n. f Histograms represent the mean ± SEM of the percentage of individual
ploidy populations of BM cells. Data correspond to 3 different experiments from 3 mouse of each genotype. Data were analyzed using the t-test. *p< 0.05
and **p< 0.01
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speed and the mobility of each megakaryocyte from the
explant.
The above results suggest that C3G may induce the
formation of a greater number of platelets. However,
platelet count from peripheral blood, performed with
a Hemavet Counter, revealed no differences betweenthe different genotypes (Fig. 6d). Additionally, no dif-
ferences were found in the platelet count between
males and females (data not shown). The analysis of
the platelet half-life excluded the possibility of a dif-
ferential platelet turnover in the different genotypes
(Additional file 5: Figure S5a & b). Moreover, no dif-
ferences were detected in the mRNA or protein
Fig. 6 C3G regulates megakaryocyte motility and promotes the
formation of proplatelets. a Transverse sections of bone marrows
from the different genotypes were plated in an incubation chamber
and maintained at 37 °C for 6 h. MKs at the periphery of the explants
were tracked under the microscope and images were acquired at
10 min intervals. Upper box plots represent the median ± SEM
velocity (μm/second) of individual megakaryocytes 6 h after their
release from bone marrow explants. Lower box plots represent the
median distance (μm) covered by megakaryocytes from bone
marrow explants. Three mice of each genotype were analyzed.
Mann Whitney U test were done. **p < 0.01, ***p < 0.001. b
Percentage of MKs most strongly associated to the osteoblastic
niche. After extraction of the bone marrow, small pieces of femur
were treated with collagenase and dispase for 2 h and the
percentage of CD61+ cells was analyzed by flow cytometry. Mann-
Whitney U test was done. c Representative images of the different
stages of MK maturation: spherical megakaryocytes, megakaryocytes
with extending protrusions and megakaryocytes with proplatelets.
Fluorescence microscope images (Left panels) and brightfield
inverted microscope images (right panels). The histograms represent
the mean ± SEM of the percentage of cells of each phenotype
measured in two different experiments, with at least 4 explants from
each genotype. d C3G did not modify platelet count. Counts were
performed in peripheral blood collected from 6-month mice of the
different genotypes using Hemavet Counter HV950FS. The
histograms represent the mean ± SEM of the number of platelets.
Mann-Whitney U test was done, but no significant differences were
observed between Tg-C3G or Tg-C3GΔCat vs WT.
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(data not shown).
Platelet C3G increases platelet counts and induces
adipogenesis in BM under pathological conditions
Considering the unexpected similar platelet counts ob-
tained in vivo, we analyzed the production of platelets
under pathological conditions. For that, we used two ap-
proaches that mimic a pathological thrombopoiesis: TPO
injection and tumor implantation. Mice were treated with
a single intraperitoneal injection of 5 μg TPO, and blood
was collected at different days post-injection to analyze
platelet production. The administration of TPO increased
the platelet count, which peaked at day 5–6, both in trans-
genic mice and in their controls (Fig. 7a & b). There was a
slight increase in the fold change of platelet number in
Tg-C3G compared to WT, which correlated with a slight
decrease in Tg-C3GΔCat versus WT. These results could
indicate a tendency of C3G to increase the production of
platelets in a stress situation in vivo.
To further investigate the effect of C3G under patho-
logical conditions, we monitored the number of platelets
in Tg-C3G and WT-C3G mice 15 days after subcutane-
ous injection of B16-F10 melanoma cells. We did not
observe differences, neither in the number of megakar-
yocytes in the bone marrow (Additional file 6: Figure
S6), nor in the number of platelets in peripheral blood
(data not shown). However, Tg-C3G showed a significant
increase in the density and size of adipocytes in the bone
marrow, as compared to WT-C3G mice (Fig. 8a-c).
Discussion
In the present work, we have demonstrated that C3G
plays a key role in the modulation of different stages of
megakaryopoiesis leading to platelet formation. This in-
cludes colony formation of MK progenitors, acquisition
of surface markers, changes in morphology, polyploidi-
zation, migration from the osteoblastic to the vascular
niche and proplatelet formation. A role for C3G in other
differentiation processes has been demonstrated, such as
those leading to adipocytes [8], neuroblastoma cells [4],
macrophages [7] and myotubes [9], which is probably a
reflect of its essential function during embryogenesis [3].
K562 and HEL cells behave as pluripotent hematopoietic
precursors, expressing features of both erythroid and mega-
karyocytic lineages when maintained under undifferentiated
conditions. In fact, both cell lines can be induced to
undergo erythroid or megakaryocytic differentiation de-
pending on the stimuli. Thus, under PMA treatment, both
cell lines exhibit characteristic features of megakaryocytes,
including large size, presence of vacuoles and long exten-
sions [16, 35, 36]. These same features were observed in
non-stimulated K562 cells overexpressing C3G, suggesting
that C3G could be involved in the modulation of
Fig. 7 C3G increases platelet production in response to TPO. Mice were injected intravenously with 5 μg TPO/mouse and blood samples were
collected at the indicated time points. a Time course of platelet counts in Tg-C3G (left panel), Tg-C3GΔCat (right panel) and their corresponding
wild-types. The graphs represent the median of the number of platelets (1000/μl) of each phenotype. b The histograms represent the mean ±
SEM of the maximum fold change in the number of platelets in blood after TPO treatment (platelet count at day 5–6 /platelet count at day 0)
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presumably acting downstream of PKC. Moreover, the
treatment with PMA for several days increased the expres-
sion of C3G in K562, and more notably in HEL cells, fur-
ther suggesting the involvement of C3G in the actions of
PMA that lead to MK differentiation. In this regard, we
have previously demonstrated the participation of C3G in
the PMA-PKC-Rap1 pathway leading to integrin αIIbβ3 ac-
tivation in mouse platelets [21]. In agreement with a puta-
tive role for C3G in MK differentiation, expression of the
megakaryocyte markers, CD41 and CD61, dramatically in-
creased in K562 cells with stable overexpression of
C3G, in the absence of any stimulus. Moreover, the
levels of MK markers induced by C3G overexpression
were similar, or even higher, than those induced by
PMA in control cells. This indicates that C3G, per se, is
capable of triggering the process by which these
erythroid-like cell lines commit to the megakaryocytic
lineage. In agreement with these findings, C3G expres-
sion is regulated by GATA-1, a transcription factor that
is implicated in megakaryocyte differentiation.
However, C3G-silencing or ablation did not induce a
decrease in the expression of these markers below the
control levels, neither under basal conditions nor under
PMA treatment. One plausible explanation is that the
levels of these markers are very low in untreated cells,which makes very difficult to detect any further de-
crease. However, we cannot rule out the possibility of the
existence of a compensatory mechanism, so that the ab-
sence of C3G would be countervailed by other Rap1-GEFs.
A potential candidate could be CalDAG-GEFI, which is
one of the most abundant GEFs in murine platelets and
plays a significant role regulating their functions [37, 38].
However, so far there are no data about any potential role
of CalDAG-GEFI in MK differentiation.
The acquisition of the megakaryocytic markers in
these cell lines was linked to the downregulation of the
erythroid ones, which is in concordance with the exist-
ence of a common precursor (MEP) for the erythroid
and megakaryocytic lineages [39]. As a consequence,
overexpression of C3G in K562 cells completely abro-
gated α-globin expression, including that induced by
Imatinib (STI-571). Similarly, although to a lesser extent,
the expression of GPA also decreased in the
C3G-overexpressing K562 cells. In addition, an increase
in the expression of GPA was evident in K562 cells upon
C3G silencing or knockout, despite the lack of effect in
the expression of the megakaryocytic markers. Similar
results were observed in primary bone marrow cells
from transgenic C3G and C3GΔCat mice, where a
higher proportion of CD41/CD61 positive cells were
found in Tg-C3G mice and a lower in Tg-C3GΔCat
Fig. 8 C3G induces adipocyte density in bone marrow after tumor implantation. B16-F10 metastatic melanoma cells (1 × 106) were injected
subcutaneously in Tg-C3G and WT-C3G mice. After 15 days of tumor growth, the bone marrow was harvested, fixed with 4% formaldehyde,
embedded in paraffin and stained with H&E. a Representative images of bone marrow from femurs of transgenic and wild type mice. b
Histogram represents the median ± SEM of the total adipocyte area relative to the bone marrow area. Mann-Whitney U test was done, but no
significant differences were observed between Tg-C3G vs WT. c Box plot represent the median of the adipocyte size (μm2) of individual
adipocytes. At least 4 different mice of each genotype were analyzed. Mann Whitney U test was done. ***p < 0.001
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gether with the greater number of CFU-MKs found in
Tg-C3G BM cultures, support a role for C3G in the
regulation of early stages of the erythroid/megakaryo-
cytic commitment.
The analysis of the DNA content in C3G overexpress-
ing and C3G silenced K562 cells indicate that C3G plays
an important role promoting polyploidy in these cells.
This correlates with the increase in nuclear size ob-
served in C3G-overexpressing K562 cells. Thus, overex-
pression of C3G increases the proportion of polyploid
cells, while its ablation induced a visible decrease. It
should be highlighted that, although these results did
not reach statistical significance, they were consistent in
the two cell lines used and in both experimental condi-
tions, i.e. C3G overexpression and C3G knockout. More-
over, a higher proportion of mature megakaryocytes
(large CD41+ cells) with a DNA content ≥8n was also
observed in the bone marrow of the Tg-C3G lineages as
compared to WT, with no differences in Tg-C3GΔCat
mice. These results corroborate the positive role played
by C3G in the acquisition of polyploid features, whichseems to be dependent on its GEF activity. The role of
C3G in the regulation of ploidy was PMA-dependent,
since no changes were observed under basal conditions
(untreated clones). We have shown that treatment with
PMA induced an increase in the phosphorylation of
C3G in Y504. The phosphorylation of C3G in this resi-
due plays an important role in its full activation, prob-
ably through the release of some auto-inhibitory
mechanisms [33, 40]. It is plausible that an increase in
C3G phosphorylation is required in later stages during
MK differentiation, but not in the initial phases to in-
duce the expression of the MK markers.
Additionally, overexpression of C3G in K562 cells pro-
duced an increase in the expression of the cell cycle in-
hibitor p21, which is known to be up-regulated during
MK differentiation [32]. An upregulation of p21 induced
by C3G overexpression also occurs in neuronal differen-
tiation, which is mediated by the ERK1/2 pathway [4].
However, p21 levels in our C3G knockout K562 cells
remained similar to those from control cells, even
though these cells reach lower levels of ploidy. A plaus-
ible explanation is that the function of C3G in the
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cycle regulators, in addition to p21. In fact, it has been
shown that p21 knockout does not rescue the mitotic ar-
rest during differentiation, indicating that its role in en-
domitosis is not essential [30]. Overall, these results
suggest that C3G could be facilitating the exit of normal
cell cycle and the entry into an endomitotic cycle.
The percentage of megakaryocytes in untreated mouse
BM cells was similar in Tg-C3G, Tg-C3GΔCat mice and
their controls (data not shown). These results indicate
that, in contrast to the observed in the cell lines, C3G
alone is not able to modulate the acquisition of MK
markers in a more physiological context, requiring an
additional stimulation, such as TPO, to potentiate this
process. An important stage in MK differentiation is the
interaction of megakaryocytes with the matrix, which
regulates the migration of megakaryocyte precursors
from the osteoblastic to the vascular niche. It has been
shown that the interaction of type I collagen with imma-
ture megakaryocytes through its main receptors, integrin
α2β1 and GPVI, inhibits the premature release of plate-
lets [41, 42]. Our results showing a lower proportion of
MKs bound to the osteoblastic matrix in Tg-C3G mice,
compared to wild type mice, indicate that C3G overex-
pression decreases the interaction between the megakar-
yocytes and the endosteal niche. Interestingly, the
proteomic analysis of platelets from Tg-C3G 2C1 mice
and their controls, revealed a differential expression of
several proteins involved in adhesion and migration, such
as Integrin-linked protein kinase, Rho GDP-dissociation
inhibitors, Cofilin-1, Tubulin β-1 chain or Actin-related
protein 3 (unpublished observations from our group),
which is in favor of a role for C3G in the regulation of ad-
hesion and migration during MK maturation. This is rein-
forced by the observation that bone marrow explants
from Tg-C3G mice contained megakaryocytes that mi-
grate at a higher speed, covering a greater distance, being
the catalytic activity of C3G responsible of this effect. Ac-
cordingly, we observed an increase in the number of
proplatelet-forming megakaryocytes in our C3G trans-
genic mice. In contrast, C3GΔCat transgenic mice showed
a reduced percentage of proplatelets, compared to their
wild type. Therefore, we can conclude that C3G, through
its catalytic, GEF domain, induces MK migration and pro-
platelet formation.
All this was not reflected in an increase in the produc-
tion of platelets in peripheral blood. However, we ob-
served a modest increase in the number of Tg-C3G
platelets after the injection of TPO, in correlation with a
decrease in Tg-C3GΔCat versus their respective controls.
This result indicates that the Tg-C3G platelets appear to
be more sensitive to TPO than the wild-type platelets,
whereas the opposite applies to the Tg-C3GΔCat platelets.
This correlates with the known role of C3G in theTPO-triggered signaling pathway [13]. In agreement with
that, platelets from Tg-C3G mice showed higher platelet
activation and aggregation in response to different platelet
agonists [21]. In addition, Tg-C3G expression increases
the capacity of platelets to induce angiogenesis and tumor
metastasis [23].
Surprisingly, although tumor implantation did not alter
the platelet count, a significant increase in adipose cells was
found in the BM from femurs of Tg-C3G mice. This sug-
gests that the forced expression of C3G in megakaryocytes
under a stress condition (i.e. tumor implantation) could in-
duce an adipogenic differentiation. Bone marrow adipocytes
(BMAs) play important roles in hematopoiesis through the
regulation of HSC function, and also participate in tumor
development and metastasis [43, 44]. These functions are
mediated by interactions with the BM microenvironment,
including HSC-derived cells, such as macrophages and
megakaryocytes [45]. Our hypothesis, supported by the role
of C3G in the regulation of platelet secretion [23], is that,
in the presence of tumor cells, C3G could enhance the abil-
ity of megakaryocytes to secrete factors that promote adi-
pogenesis. Further studies will be conducted to address this
hypothesis.
Conclusion
In summary, our results unveiled a novel function of
C3G as a promoter of megakaryocyte differentiation,
maturation and proplatelet formation. This might be
relevant, not only for physiological megakaryopoiesis,
but also for pathological processes involving platelets,
such as cancer or cardiovascular diseases. Our results
are compatible with a scenario in which TPO triggers
MK differentiation and platelet formation through the
activation of a C3G-Rap1 signaling pathway. Future
studies should aim at discerning the precise physio-
logical and pathological function of this effect of C3G
favoring megakaryopoiesis under specific conditions.
Additional files
Additional file 1: Figure S1. C3G regulates the size and morphology of
K562 cells. a Representative immunofluorescence confocal microscopy
images of the indicated K562 clones stained with rabbit anti-C3G anti-
serum #1008 and DAPI. All clones express the GFP protein, encoded in
the pSuper plasmid (pSuper.gfp/neo from Oligoengine). Images were ob-
tained using a Leica TCS SP5 confocal microscope. Scale bars: 25 μm. b
May-Grünwald-Giemsa staining of K562 clones with silenced C3G expres-
sion, untreated or treated with 20 nM PMA for 72 h. Scale bars: 10 μm. c
Expression of CD41 and CD61 markers was analyzed by flow cytometry
using specific fluorochrome-conjugated antibodies (CD41-APC and CD61-
PE). Histograms represent the mean ± SEM of the fluorescence intensity
(relative units) of CD41 and CD61 from at least 4 independent experi-
ments of each clone. 2-way ANOVA and Holm-Sidak analysis were done.
**p < 0.01. (JPG 1563 kb)
Additional file 2: Figure S2. Stable C3G silencing and knockout in K562
and HEL cell lines increase the expression of GPA. a The expression of
CD41, CD61 and GPA markers was analyzed by flow cytometry using
Ortiz-Rivero et al. Cell Communication and Signaling          (2018) 16:101 Page 16 of 17specific fluorochrome-conjugated antibodies (CD41-APC, CD61-PE and
GPA-PE). Representative flow cytometry plots of untreated cells are
shown. Histograms represent the mean ± SEM of the fluorescence intensity
(relative units) of CD41, CD61 and GPA from at least 4 independent experi-
ments of each clone, treated as indicated. 2-way ANOVA and Holm-Sidak
analysis were done. *p < 0.05, **p < 0.01, ***p < 0.001. b Representative
Western blots showing the decreased, or abrogated, expression of C3G in
the three clones used. Values are relative to cells transfected with empty
vectors. The expression of tubulin was used as loading control. C3G/Tubulin
ratios are shown. c Analysis of CD61 and GPA mRNA expression by RT-PCR
in the untreated K562 clones: pSuper-CT and pSuper-C3Gi. The numbers
represent expression values relative to pLTR2-CT expressing cells and
normalized against GAPDH, used as housekeeping gene. (JPG 578 kb)
Additional file 3: Figure S3. Negative controls of immunofluorescence
Rap1 activation assay. The staining of Ral-GDS-RBD negative control was
made without the Ral-GDS-RBD purified protein. Anti-GST and anti-p-C3G
negative controls were made without the corresponding primary anti-
bodies. Scale bars: 7.5 μm. (JPG 1284 kb)
Additional file 4: Figure S4. The RAPGEF1 locus shows binding sites for
hematopoietic transcription factors. Alignment of the sequences
conserved throughout the evolution in the C3G gene and in its flaking
regions in opossum, rat, mouse, dog and cow, with respect to the
human ortholog, obtained from the ECR browser database. The
alignment is divided into 2 fragments representing the 3′ intergenic
region and a large part of the gene (a) followed by the remaining part of
the gene and the 5′ intergenic region (b). Peak intensity represents the
degree of similarity, between 50 and 100%. In the upper part the human
C3G gene is represented in blue. C3G transcript gives rise to two main
splicing variants (a and b). Yellow arrows indicate the first exon of each
variant. Exons are represented in blue, introns in salmon, intergenic
regions in red, repetitive loci in green and untranslated regions (UTR) in
yellow. The peaks corresponding to binding sites for specific
hematopoietic transcription factors (HTF), are indicated by black arrows. c
Representation of the HTF binding sites to the C3G gene conserved
throughout evolution (up to mouse), and the regions in which HTF
binding has been demonstrated by ChIP experiments (UCSC, Santa Cruz,
California). HTFs whose binding has been demonstrated are represented
as pins that indicate the DNA binding site. GATA-1 and GATA-2 sites are
represented in purple, E2A sites in yellow, TAL-1 sites in blue and NFE2
sites in red. Black vertical lines show conserved transcription factor bind-
ing sequences. (JPG 3616 kb)
Additional file 5: Figure S5. Tg-C3G and WT-C3G platelets have a similar
clearance. Histograms represent the mean ± SEM of the peripheral biotinyl-
ated platelets collected from Tg-C3G (a), Tg-C3GΔCat (b) and their wild type
mice after 24, 48, 72, and 96 h of the NHS-Biotin injection. (JPG 170 kb)
Additional file 6: Figure S6. C3G did not modify megakaryocyte levels
in bone marrow after tumor implantation. a Histogram represents the
mean ± SEM of the percentage of CD41 and CD61 positive BM cells from
femurs of the indicated genotypes, analyzed by flow cytometry with anti-
CD41-APC and anti-CD61-PE antibodies. b Histogram represents the
number of MKs per area of bone marrow. Data was analyzed by Ariol
software. Mann-Whitney U test was done, but no significant differences
were observed between Tg-C3G vs WT. (JPG 159 kb)
Additional file 7: Video S1. Representative video showing the mobility
of megakaryocytes from an explant. The images of the videos were used
to calculate the speed and distance covered by the megakaryocytes,
which is shown in Fig. 6a. (AVI 6619 kb)
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